Literature DB >> 19028118

Considerations for implantation site of VX2 carcinoma into rabbit liver.

Kwang-Hun Lee1, Eleni Liapi, Manon Buijs, Josephina Vossen, Kelvin Hong, Christos Georgiades, Jean-Francois H Geschwind.   

Abstract

PURPOSE: To assess whether the implantation site of VX2 carcinoma into rabbit liver affects successful vessel selection for transcatheter arterial interventions.
MATERIALS AND METHODS: Twenty-four New Zealand White rabbits were randomly assigned to two groups. All implantations were performed by open laparotomy with minced tumor cells inserted into a 16-gauge Angiocath needle. Group I rabbits (n = 12) had tumor implanted into the left medial lobe of the liver and group II rabbits (n = 12) had tumor implanted into the left lateral lobe. Two weeks after implantation, selective angiography was performed for subsequent chemoembolization, which was part of a different study. Tested variables included maximum tumor diameter, tumor feeding artery size, and tumor vascularity.
RESULTS: Successful tumor growth was achieved in all rabbits. Selective angiography was possible in 33.3% of rabbits in group I and 66.6% of rabbits in group II (P < .05). Tumor size and vascularity were similar between groups. Mean lengths of tumor feeder arteries from the bifurcation of the left hepatic artery were 4.1 mm +/- 1.2 in group I (left medial lobe) and 10.8 mm +/- 3.0 in group II (left lateral lobe; P < .05). The angulation of the left medial lobar artery (group I) off the left hepatic artery was acute in eight of 12 rabbits (66.6%), but only four of 12 rabbits in group II (33.3%) showed acute angulation of the left lateral lobar artery off the left hepatic artery (P < .05). Mean angiography time was significantly shorter in group II.
CONCLUSIONS: For selective hepatic arterial interventions, the left lateral lobe of the liver may be favorable as an implantation site for VX2 tumors in rabbits.

Entities:  

Mesh:

Year:  2008        PMID: 19028118      PMCID: PMC2747297          DOI: 10.1016/j.jvir.2008.09.033

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

1.  Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis.

Authors:  J F Geschwind; D Artemov; S Abraham; D Omdal; M S Huncharek; C McGee; A Arepally; D Lambert; A C Venbrux; G B Lund
Journal:  J Vasc Interv Radiol       Date:  2000 Nov-Dec       Impact factor: 3.464

2.  New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

Authors:  Kelvin Hong; Afsheen Khwaja; Eleni Liapi; Michael S Torbenson; Cristos S Georgiades; Jean-Francois H Geschwind
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

3.  Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods.

Authors:  Wan-Yu Lin; Jeonhor Chen; Yungchang Lin; Kunwang Han
Journal:  J Vet Med Sci       Date:  2002-07       Impact factor: 1.267

4.  Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer.

Authors:  Kelvin Hong; Hisham Kobeiter; Christos S Georgiades; Michael S Torbenson; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

5.  Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver.

Authors:  B Izumi; S Tashiro; Y Miyauchi
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

6.  Radiologic anatomy of the rabbit liver on hepatic venography, arteriography, portography, and cholangiography.

Authors:  T S Seo; J H Oh; D H Lee; Y T Ko; Y Yoon
Journal:  Invest Radiol       Date:  2001-03       Impact factor: 6.016

7.  Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods.

Authors:  J H Chen; Y C Lin; Y S Huang; T J Chen; W Y Lin; K W Han
Journal:  Lab Anim       Date:  2004-01       Impact factor: 2.471

8.  Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.

Authors:  Sumeet Virmani; Dingxin Wang; Kathleen R Harris; Robert K Ryu; Kent T Sato; Robert J Lewandowski; Albert A Nemcek; Barbara Szolc-Kowalska; Gayle Woloschak; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2007-10       Impact factor: 3.464

9.  Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit.

Authors:  F A Burgener; M R Violante
Journal:  Invest Radiol       Date:  1979 Sep-Oct       Impact factor: 6.016

  9 in total
  11 in total

1.  Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma.

Authors:  Zhu Chen; Zhen Kang; En-Hua Xiao; Min Tong; Yu-Dong Xiao; Hua-Bing Li
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

2.  Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study.

Authors:  Anilchandra Attaluri; Madhav Seshadri; Sahar Mirpour; Michele Wabler; Thomas Marinho; Muhammad Furqan; Haoming Zhou; Silvia De Paoli; Cordula Gruettner; Wesley Gilson; Theodore DeWeese; Monica Garcia; Robert Ivkov; Eleni Liapi
Journal:  Int J Hyperthermia       Date:  2016-05-05       Impact factor: 3.914

3.  Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles.

Authors:  Chen Yang; Ran Zhu; Jianmei Wan; Bo Jiang; Dayong Zhou; Miaoli Song; Fenju Liu
Journal:  Cancer Biother Radiopharm       Date:  2014-11       Impact factor: 3.099

4.  Rabbit hepatic arterial anatomy variations: implications on experimental design.

Authors:  Alda L Tam; Marites P Melancon; Joe Ensor; Yang Liu; Katherine Dixon; Amanda McWatters; Sanjay Gupta
Journal:  Acta Radiol       Date:  2013-11-29       Impact factor: 1.990

Review 5.  Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and "how to" guide.

Authors:  Ahmad Parvinian; Leigh C Casadaban; Ron C Gaba
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

6.  Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.

Authors:  Veronica Prieto; Johannes M Ludwig; Alton B Farris; Ganji Purnachandra Nagaraju; Taoreed O Lawal; Bassel El-Rayes; Hyun S Kim
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

7.  99mTc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumors.

Authors:  Ross W Stephens; Gregory D Tredwell; Karen J Knox; Lee A Philip; David W King; Kelly M Debono; Jessica L Bell; Tim J Senden; Marcel R Tanudji; Jillean G Winter; Stephanie A Bickley; Michael J Tapner; Stephen K Jones
Journal:  Int J Nanomedicine       Date:  2019-01-31

8.  In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites.

Authors:  Ross W Stephens; Gregory D Tredwell; Jessica L Bell; Karen J Knox; Lee A Philip; Tim J Senden; Michael J Tapner; Stephanie A Bickley; Marcel R Tanudji; Stephen K Jones
Journal:  Biomater Res       Date:  2021-03-31

Review 9.  Current Challenges in Image-Guided Magnetic Hyperthermia Therapy for Liver Cancer.

Authors:  Anirudh Sharma; Erik Cressman; Anilchandra Attaluri; Dara L Kraitchman; Robert Ivkov
Journal:  Nanomaterials (Basel)       Date:  2022-08-12       Impact factor: 5.719

10.  Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.

Authors:  Yong Du; Angel Cortez; Anders Josefsson; Mohammadreza Zarisfi; Rebecca Krimins; Eleni Liapi; Jessie R Nedrow
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.